Tag Archive | clinical trials
Day three of the BIO International Convention focused on an uncertain future for the biotech industry and looked ahead to new innovations in disease research.
Day two of the BIO International Convention focused on how the private and public sectors can work together to solve global health challenges.
Follow all this week as Science Life reports from the 20th annual BIO International Convention on biotech, research and innovation.
Like so many promising partnerships, it began with a mixed drink. In 1989, some pharmacists wanted to study the effects of alcohol consumption on a calcium-channel blocker. To mask the flavor of alcohol, they mixed it with grapefruit juice. The alcohol, they discovered, made no difference. Yet blood pressures plummeted and drug levels increased dramatically, […]
The phone call came in early October, 2011. “You could sense the tone of it right away,” recalls pulmonologist Imre Noth, MD, who runs one of the country’s largest practices for patients with pulmonary fibrosis. “There was just something about the voice on the line.” The conference call came from the data and safety monitoring […]
Medical imaging has become a crucial tool for diagnosis and clinical research. Imaging services in an academic medical institution like the University of Chicago Medicine are used by dozens of departments for everyday patient care and clinical trials, making them subject to a bewildering array of policies and procedures to protect patient privacy and preserve […]
Exercise is increasingly an important component of treating Parkinson’s disease. To supplement the effects of medication or surgery, Parkinson’s patients may undergo physical therapy or programs such as Tai Chi to improve motor symptoms including balance, gait, and tremor. Generally, the idea behind these exercises is to strengthen the body’s muscles to compensate for the […]
“A pox of this gout! or a gout of this pox! for the one or the other plays the rogue with my great toe.” – Falstaff, Henry IV Gout was once called “the king of diseases and the disease of kings.” Thanks to that proximity to power, gout has been well documented through history, from […]
Let’s start with a statistic: almost 2,000 citations a year. One paper by Paul Meier, the Ralph and Mary Otis Isham Distinguished Service Professor emeritus of statistics, pharmacological and physiological sciences, medicine, and the college, has been cited more often, by a wide margin, than any other paper in the field. At last count it […]